10694556

Source:http://linkedlifedata.com/resource/pubmed/id/10694556

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0194810, umls-concept:C0279025, umls-concept:C0332283, umls-concept:C0600558, umls-concept:C1548161
pubmed:issue	5
pubmed:dateCreated	2000-3-24
pubmed:abstractText	We assessed the feasibility and efficacy of integrating chemotherapy and androgen ablation with radical prostatectomy in patients with locally advanced prostate cancer. The neoadjuvant approach was adopted because it allows an in situ assessment of antitumoral activity.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Androgens, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Estramustine, http://linkedlifedata.com/resource/pubmed/chemical/Ketoconazole, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0732-183X
pubmed:author	pubmed-author:FinkOO, pubmed-author:KamoiKK, pubmed-author:LogothetisC JCJ, pubmed-author:PettawayC ACA, pubmed-author:PistersL LLL, pubmed-author:SlatonJJ, pubmed-author:TroncosoPP
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1050-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10694556-Adult, pubmed-meshheading:10694556-Aged, pubmed-meshheading:10694556-Androgen Antagonists, pubmed-meshheading:10694556-Androgens, pubmed-meshheading:10694556-Antineoplastic Agents, Hormonal, pubmed-meshheading:10694556-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10694556-Combined Modality Therapy, pubmed-meshheading:10694556-Doxorubicin, pubmed-meshheading:10694556-Estramustine, pubmed-meshheading:10694556-Feasibility Studies, pubmed-meshheading:10694556-Follow-Up Studies, pubmed-meshheading:10694556-Humans, pubmed-meshheading:10694556-Ketoconazole, pubmed-meshheading:10694556-Male, pubmed-meshheading:10694556-Middle Aged, pubmed-meshheading:10694556-Neoadjuvant Therapy, pubmed-meshheading:10694556-Prostate-Specific Antigen, pubmed-meshheading:10694556-Prostatectomy, pubmed-meshheading:10694556-Prostatic Neoplasms, pubmed-meshheading:10694556-Vinblastine
pubmed:year	2000
pubmed:articleTitle	Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results.
pubmed:affiliation	Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. cpettawa@mdanderson.org
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I